NDLI: Gene correction in patient-specific iPSCs for therapy development and disease modeling

Content Provider	Springer Nature Link
Author	Jang, Yoon Young Ye, Zhaohui
Copyright Year	2016
Abstract	The discovery that mature cells can be reprogrammed to become pluripotent and the development of engineered endonucleases for enhancing genome editing are two of the most exciting and impactful technology advances in modern medicine and science. Human pluripotent stem cells have the potential to establish new model systems for studying human developmental biology and disease mechanisms. Gene correction in patient-specific iPSCs can also provide a novel source for autologous cell therapy. Although historically challenging, precise genome editing in human iPSCs is becoming more feasible with the development of new genome-editing tools, including ZFNs, TALENs, and CRISPR. iPSCs derived from patients of a variety of diseases have been edited to correct disease-associated mutations and to generate isogenic cell lines. After directed differentiation, many of the corrected iPSCs showed restored functionality and demonstrated their potential in cell replacement therapy. Genome-wide analyses of gene-corrected iPSCs have collectively demonstrated a high fidelity of the engineered endonucleases. Remaining challenges in clinical translation of these technologies include maintaining genome integrity of the iPSC clones and the differentiated cells. Given the rapid advances in genome-editing technologies, gene correction is no longer the bottleneck in developing iPSC-based gene and cell therapies; generating functional and transplantable cell types from iPSCs remains the biggest challenge needing to be addressed by the research field.
Starting Page	1041
Ending Page	1058
Page Count	18
File Format	PDF
ISSN	03406717
Journal	Human Genetics
Volume Number	135
Issue Number	9
e-ISSN	14321203
Language	English
Publisher	Springer Berlin Heidelberg
Publisher Date	2016-06-02
Publisher Place	Berlin, Heidelberg
Access Restriction	One Nation One Subscription (ONOS)
Subject Keyword	Human Genetics Molecular Medicine Gene Function Metabolic Diseases
Content Type	Text
Resource Type	Article
Subject	Genetics Genetics (clinical)

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Genome-editing technologies for gene correction of hemophilia

Modeling human neurodegenerative diseases in transgenic systems

Genomic medicine and neurological disease

Mouse models of SMA: tools for disease characterization and therapeutic development

Human gene copy number variation and infectious disease

Treating hemoglobinopathies using gene-correction approaches: promises and challenges

Metabolic heritability at birth: implications for chronic disease research

CRISPR/Cas9 in zebrafish: an efficient combination for human genetic diseases modeling

Homocysteine in Health and Disease

Gene correction in patient-specific iPSCs for therapy development and disease modeling

Similar Documents

Genome-editing technologies for gene correction of hemophilia

Modeling human neurodegenerative diseases in transgenic systems

Genomic medicine and neurological disease

Mouse models of SMA: tools for disease characterization and therapeutic development

Human gene copy number variation and infectious disease

Treating hemoglobinopathies using gene-correction approaches: promises and challenges

Metabolic heritability at birth: implications for chronic disease research

CRISPR/Cas9 in zebrafish: an efficient combination for human genetic diseases modeling

Homocysteine in Health and Disease

Gene correction in patient-specific iPSCs for therapy development and disease modeling